RHUMBLINE ADVISERS - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 102 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$219,000
-62.1%
43,959
-3.8%
0.00%
-100.0%
Q4 2020$578,000
+49.0%
45,719
+15.7%
0.00%0.0%
Q3 2020$388,000
-14.9%
39,506
-13.8%
0.00%0.0%
Q2 2020$456,000
+27.7%
45,815
+13.5%
0.00%0.0%
Q1 2020$357,000
+13.3%
40,349
+18.0%
0.00%0.0%
Q4 2019$315,000
+57.5%
34,194
+0.6%
0.00%
Q3 2019$200,000
-46.2%
33,984
+9.7%
0.00%
-100.0%
Q2 2019$372,000
+0.3%
30,986
+0.8%
0.00%0.0%
Q1 2019$371,000
-5.4%
30,743
-1.7%
0.00%0.0%
Q4 2018$392,000
+20.2%
31,261
+42.4%
0.00%0.0%
Q3 2018$326,000
-10.4%
21,948
+1.4%
0.00%0.0%
Q2 2018$364,000
-9.2%
21,637
+23.5%
0.00%0.0%
Q1 2018$401,000
-10.1%
17,513
+1.5%
0.00%0.0%
Q4 2017$446,000
+47.7%
17,248
-15.6%
0.00%0.0%
Q3 2017$302,000
+6.7%
20,448
+1.0%
0.00%0.0%
Q2 2017$283,000
-11.6%
20,253
+8.0%
0.00%0.0%
Q1 2017$320,000
+74.9%
18,753
+5.5%
0.00%
Q4 2016$183,000
+3.4%
17,777
+1.8%
0.00%
Q3 2016$177,000
-8.8%
17,458
+1.2%
0.00%
-100.0%
Q2 2016$194,000
-4.4%
17,248
+16.3%
0.00%0.0%
Q1 2016$203,000
-27.2%
14,834
+0.8%
0.00%0.0%
Q4 2015$279,000
+8.1%
14,709
+6.9%
0.00%0.0%
Q3 2015$258,000
+31.6%
13,754
+4.4%
0.00%0.0%
Q2 2015$196,00013,1800.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Kynam Capital Management, LP 4,420,349$25,814,8383.96%
Parkman Healthcare Partners LLC 1,203,484$7,028,3471.87%
SPHERA FUNDS MANAGEMENT LTD. 1,002,783$5,856,2531.26%
TANG CAPITAL MANAGEMENT LLC 1,150,000$6,716,0000.98%
BVF INC/IL 3,629,000$21,193,3600.89%
Nantahala Capital Management 1,732,388$10,117,1460.66%
AWM Investment Company, Inc. 666,661$3,893,3000.56%
INGALLS & SNYDER LLC 1,295,833$7,5680.41%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 200,800$1,172,6720.36%
Kensington Investment Counsel, LLC 58,599$342,2180.27%
View complete list of CONCERT PHARMACEUTICALS INC shareholders